Could a Preoperative Feeding Jejunostomy Decrease Sarcopenia for Patients With Oesogastric Adenocarcinoma ?

Sarcopenia Clinical Trial

Official title:

Could a Preoperative Feeding Jejunostomy Decrease Sarcopenia for Patients With Oesogastric Adenocarcinoma ?

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03574116
• Other study ID #: 6808
• Status: Recruiting
• Start date: May 31, 2018
• Est. completion date: May 2019

Study information

• Verified date: May 2018
• Source: University Hospital, Strasbourg, France
• Contact: Francis VEILLON, MD, PhD
• Phone: 33 3 88 12 78 65
• Email: Francis.veillon[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study of sarcopenia is a subject that is the subject of numerous research and publications, particularly because of its link with a poor prognosis for many cancers.

In an article published by the digestive surgery team, the role of feeding jejunostomy has been demonstrated: it allowed more patients to reach the 2nd stage of surgery and a better tolerance of chemotherapy.

Investigators wanted to study retrospectively the impact of feeding jejunostomy on radiological sarcopenia. Is the positive effect of jejunostomy in gastric cancers associated with a decrease in sarcopenia?

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: May 2019
• Est. primary completion date: May 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Criteria for inclusion:

• Age 18-80 years

• Sex: H or F

• Subject giving their consent for their participation

• Gastric cancers

• stage> IB

• whether or not a feeding jejunostomy

• CT scan performed at the HUS, after the end of the courses of chemotherapy and / or before the surgery.

Exclusion criteria:

• antecedent level L3 surgery,

• psoas hematoma

• No CT performed at HUS at the end of chemotherapy and / or before surgery

• Impossibility of giving the subject informed information

• Subject under the protection of justice

• Subject under guardianship or curatorship

Related Conditions & MeSH terms

• Adenocarcinoma
• Sarcopenia

Locations

Country	Name	City	State
France	Service Imagerie 1	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate muscle status by CT evaluation of sarcopenia in patients	Evaluate the impact of feeding jejunostomy in patients with gastric cancer	24 hour after the realization of the MRI